English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Identification of Novel Targets for Lung Cancer Therapy Using an Induced Pluripotent Stem Cell Model Journal article
Shukla, V, Rao, M, Zhang, HE, Beers, J, Wangsa, D, Wangsa, D, Buishand, FO, Wang, YH, Yu, ZY, Stevenson, H, Reardon, E, McLoughlin, KC, Kaufman, A, Payabyab, E, Hong, JA, Zhang, M, Davis, SR, Edelman, DC, Chen, G, Miettinen, M, Restifo, N, Ried, T, Meltzer, PS, Schrump, DS. Identification of Novel Targets for Lung Cancer Therapy Using an Induced Pluripotent Stem Cell Model[J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15, S127-S128.
Authors:  Shukla, V;  Rao, M;  Zhang, HE;  Beers, J;  Wangsa, D; et al.
Favorite | TC[WOS]:1   IF:6.8/6.8 | Submit date：2019/01/09
ASXL3 is a novel pluripotency factor in human respiratory epithelial cells and a potential therapeutic target in small cell lung cancer Journal article
Shukla V., Rao M., Zhang H., Beers J., Wangsa D., Wangsa D., Buishand F.O., Wang Y., Yu Z., Stevenson H.S., Reardon E.S., McLoughlin K.C., Kaufman A.S., Payabyab E.C., Hong J.A., Zhang M., Davis S., Edelman D., Chen G., Miettinen M.M., Restifo N.P., Ried T., Meltzer P.A., Schrump D.S.. ASXL3 is a novel pluripotency factor in human respiratory epithelial cells and a potential therapeutic target in small cell lung cancer[J]. Cancer Research, 2017, 77(22), 6267-6281.
Authors:  Shukla V.;  Rao M.;  Zhang H.;  Beers J.;  Wangsa D.; et al.
Favorite | TC[WOS]:21 TC[Scopus]:20 | Submit date：2018/12/21